JUL 01, 2020 12:15 PM SGT

Simplify your journey of molecular profiling with single day NGS

Speaker
  • Jon Sherlock, PhD

    Director of Product Management, Oncology , Clinical Sequencing Division, Thermo Fisher Scientific, USA
    BIOGRAPHY

Abstract

Learn about how the new Ion Torrent Genexus System is addressing key challenges to next-generation sequencing (NGS) implementation, like hands-on time, time-to-result, user expertise, and affordability. 

Ion Torrent Genexus System in combination with the new Oncomine Precision Assay, represents a new-generation solution for genomic profiling of cancer samples and enables a broad spectrum of labs, even without previous expertise, to provide fast genomic profiling. We will also discuss the importance of detecting both novel fusions and known fusions via FusionSync detection technology.  

Introducing Oncomine Myeloid assay on Genexus to simplify and accelerate myeloid profiling where users can simultaneously interrogate all relevant DNA mutations and fusion transcripts for research on myeloid malignancies.  The single-day turnaround time allowing you to provide a full myeloid NGS profile at the same time as other molecular test results.